biotech

Despite some negative performers, there were still a number of companies that experienced significant share price gains.

Australian biotech and pharma had a number of key results in May with several stocks rallying. I look at 6 companies on the move.

The rising pace of M&A within the global biotech industry is playing a key role the sector's recovery, a dynamic we expect to continue.

April continued to be a strong month for Australian pharma and biotech companies with a number of successful trials, and contracts, with potential for global...

March witnessed plenty of movers and shakers in the biotech industry, with a number of key successes in trials, and others showing strong results, leading strong...

The best opportunities are found when you don't follow the herd.

Welcome to the first edition of the IIR Movers & Shakers report for Pharma & Biotech. Each month, we will be looking at those stocks that experience significant share...

Megatrends might be a growth investor’s buzzword, but what are the trends to look at and where can you find the right companies? It’s easy to get caught up in hype...

Rett syndrome is a rare genetic neurological disorder that affects the way the brain develops, causing the progressive loss of motor skills and speech. In March 2020,...

John McBain has had quite the varied career, starting out as a OB-GYN, pioneering IVF treatment in Australia, and then finding success as a small cap investor. If you...